What's new? Log in Free sign up

Scilex Holding (SCLX)

Company Profile

Company profile

Ticker

SCLX, SCLXW

Exchange

Website

www.scilexholding.com

CEO

Mr. Jaisim Shah

Incorporated

Location

Fiscal year end

Industry (SIC)

Biological Products, (No Diagnostic Substances)

Biomotion Sciences Ordinary Shares • Amgen • Gilead Sciences • Biogen • Qiagen • Sterling Check • Bio-Techne • Moderna • Acorda Therapeutics • Saratoga Investment ...

Former names

Scilex Holding Company/DE, Vickers Vantage Corp. I

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

SCLX stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

D. Boral Capital

Latest filings (excl ownership)

View all

Prospectus supplement

Prospectus supplement

Definitive proxy

Entry into a Material Definitive Agreement

Preliminary revised proxy

Preliminary proxy

Prospectus supplement

Prospectus supplement

Entry into a Material Definitive Agreement

Prospectus supplement

Latest ownership filings

View all

SCLX Stock Acquisition JV LLC

Change in insider ownership

Change in insider ownership

ORAMED PHARMACEUTICALS INC.

Change in insider ownership

SCLX Stock Acquisition JV LLC

Dorman Followwill

Yue Alexander Wu

Financial summary

Financial statements Chart SCLX financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	8.12 mm	8.12 mm	8.12 mm	8.12 mm	8.12 mm	8.12 mm
Cash burn (monthly)	516.67 k	(no burn)	6.64 mm	8.61 mm	(no burn)	(no burn)
Cash used (since last report)	2.62 mm	n/a	33.61 mm	43.56 mm	n/a	n/a
Cash remaining	5.50 mm	n/a	-25.49 mm	-35.45 mm	n/a	n/a
Runway (months of cash)	10.6	n/a	-3.8	-4.1	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

SCLX institutional ownership history Ownership history

51.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	94	92	+2.2%
Opened positions	9	14	-35.7%
Closed positions	7	23	-69.6%
Increased positions	23	13	+76.9%
Reduced positions	14	18	-22.2%

13F shares	Current	Prev Q	Change
Total value	30.88 bn	76.32 bn	-59.5%
Total shares	125.22 mm	131.36 mm	-4.7%
Total puts	56.60 k	23.50 k	+140.9%
Total calls	102.70 k	122.70 k	-16.3%
Total put/call ratio	0.6	0.2	+187.8%

Largest owners	Shares	Value	Change
SCLX Stock Acquisition JV	89.62 mm	$0.00	0.0%
STT State Street	7.48 mm	$6.92 bn	+0.7%
BlackRock	6.71 mm	$6.20 bn	NEW
Vanguard	6.04 mm	$5.59 bn	+13.1%
Armistice Capital	3.51 mm	$3.25 bn	-70.6%
SRNE Sorrento Therapeutics	1.92 mm	$3.36 mm	0.0%
Millennium Management	1.46 mm	$1.35 bn	+466.2%
Geode Capital Management	1.30 mm	$1.20 bn	+0.5%
NTRS Northern Trust	776.79 k	$718.22 mm	-0.2%
D. E. Shaw & Co.	627.04 k	$579.76 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Armistice Capital	3.51 mm	-8.44 mm	-70.6%
BlackRock	6.71 mm	+6.71 mm	NEW
BLK BlackRock	0.00	-6.71 mm	EXIT
Millennium Management	1.46 mm	+1.20 mm	+466.2%
Vanguard	6.04 mm	+700.95 k	+13.1%
C Citigroup	562.71 k	+479.63 k	+577.3%
Norges Bank	0.00	-477.62 k	EXIT
Citadel Advisors	596.15 k	+437.56 k	+275.9%
Laurion Capital Management	0.00	-257.79 k	EXIT
Jane Street	30.16 k	-247.27 k	-89.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SCLX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
21 Jan 25	SCLX Stock Acquisition JV	Common Stock	Other	Dispose J	No	No	0	3,250,000	0.00	51,039,214
16 Jan 25	SCLX Stock Acquisition JV	Common Stock	Other	Dispose J	No	No	0	779,371	0.00	54,289,214
2 Jan 25	SCLX Stock Acquisition JV	Common Stock	Other	Dispose J	No	No	0	5,000,000	0.00	55,068,585
18 Dec 24	Shah Jaisim	Common Stock	Buy	Acquire P	No	No	0.46	30,000	13.80 k	139,333
16 Dec 24	Jay Chun	Nonstatutory Stock Option Common Stock	Grant	Acquire A	No	No	0.5045	100,000	50.45 k	100,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

D. Boral Capital Maintains Buy on Scilex Holding, Maintains $22 Price Target

D. Boral Capital analyst Jason Kolbert maintains Scilex Holding (NASDAQ:SCLX) with a Buy and maintains $22 price target.

U.S. Bankruptcy Court has Extends Lockup Period On Shares Of Scilex Dividend Stock Previously Distributed By Sorrento

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any shares of the

This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

D. Boral Capital Initiates Coverage On Scilex Holding with Buy Rating, Announces Price Target of $22

Scilex Announced FDA Acknowledgment Of SNDA Submission For ELYXYB In Acute Pain Indication

Press releases

From Benzinga Pro

Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination

NEW YORK, NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any shares of the

Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)

PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing

Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.